Groupama Asset Managment decreased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 81.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,111 shares of the semiconductor company's stock after selling 4,857 shares during the quarter. Groupama Asset Managment's holdings in Synopsys were worth $541,000 as of its most recent SEC filing.
Several other institutional investors have also bought and sold shares of the business. Kieckhefer Group LLC purchased a new position in shares of Synopsys during the fourth quarter valued at approximately $27,000. Whipplewood Advisors LLC bought a new position in Synopsys in the 4th quarter valued at $33,000. Sierra Ocean LLC bought a new stake in shares of Synopsys during the fourth quarter worth $39,000. Hazlett Burt & Watson Inc. boosted its stake in shares of Synopsys by 28.6% during the fourth quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock valued at $44,000 after purchasing an additional 20 shares during the period. Finally, Newbridge Financial Services Group Inc. bought a new position in shares of Synopsys in the fourth quarter worth about $51,000. Institutional investors own 85.47% of the company's stock.
Synopsys Stock Performance
Shares of NASDAQ:SNPS traded up $47.11 during trading on Wednesday, reaching $428.70. The stock had a trading volume of 2,145,046 shares, compared to its average volume of 1,083,945. The business has a fifty day moving average price of $461.83 and a 200-day moving average price of $499.45. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $624.80. The stock has a market cap of $66.29 billion, a PE ratio of 29.52, a PEG ratio of 3.23 and a beta of 1.23.
Analyst Upgrades and Downgrades
A number of brokerages have recently commented on SNPS. Needham & Company LLC reaffirmed a "buy" rating and set a $650.00 target price on shares of Synopsys in a research report on Thursday, February 27th. Rosenblatt Securities restated a "buy" rating and set a $660.00 price objective on shares of Synopsys in a report on Tuesday, February 25th. Piper Sandler dropped their price target on Synopsys from $655.00 to $653.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Morgan Stanley decreased their price objective on Synopsys from $625.00 to $590.00 and set an "overweight" rating for the company in a report on Monday, February 24th. Finally, Redburn Atlantic assumed coverage on shares of Synopsys in a report on Monday, January 13th. They issued a "buy" rating and a $600.00 price target for the company. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $638.58.
Read Our Latest Stock Report on SNPS
Insider Activity
In related news, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total value of $5,270,982.50. Following the sale, the chief executive officer now owns 70,922 shares in the company, valued at approximately $32,890,077.50. The trade was a 13.81 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CRO Richard S. Mahoney sold 20,838 shares of the company's stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the sale, the executive now directly owns 1,460 shares in the company, valued at $738,774.60. This represents a 93.45 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 47,909 shares of company stock valued at $22,794,835. 0.62% of the stock is currently owned by company insiders.
About Synopsys
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
